Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Non Operating Income: 2019-2024

Historic Non Operating Income for GeneDx Holdings (WGS) over the last 6 years, with Dec 2024 value amounting to -$29.4 million.

  • GeneDx Holdings' Non Operating Income fell 461.63% to -$4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.5 million, marking a year-over-year increase of 69.98%. This contributed to the annual value of -$29.4 million for FY2024, which is 853.68% down from last year.
  • Per GeneDx Holdings' latest filing, its Non Operating Income stood at -$29.4 million for FY2024, which was down 853.68% from $3.9 million recorded in FY2023.
  • Over the past 5 years, GeneDx Holdings' Non Operating Income peaked at $200.8 million during FY2021, and registered a low of -$29.4 million during FY2024.
  • Moreover, its 3-year median value for Non Operating Income was $3.9 million (2023), whereas its average is $14.7 million.
  • Per our database at Business Quant, GeneDx Holdings' Non Operating Income surged by 7,556.71% in 2021 and then slumped by 853.68% in 2024.
  • Yearly analysis of 5 years shows GeneDx Holdings' Non Operating Income stood at $2.6 million in 2020, then spiked by 7,556.71% to $200.8 million in 2021, then plummeted by 65.32% to $69.6 million in 2022, then slumped by 94.39% to $3.9 million in 2023, then plummeted by 853.68% to -$29.4 million in 2024.